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ABSTRAK
Tujuan: untuk mengetahui keamanan dan efektivitas dosis hormon testosteron undecanoate (TU) dan depot 
medroxyprogesterone acetate (DMPA) guna mengembangkan potensi kontrasepsi pria. Metode: dilakukan penekanan 
kadar sperma tikus melalui peningkatan apoptosis sel germinal secara in vivo melalui pemberian androgen kerja 
panjang yang merupakan kombinasi TU dan DMPA. Tikus jenis Sprague-Dawley dewasa diberi TU dengan dosis 2,5 
mg setiap 6 minggu dan DMPA 1,25 mg setiap 12 minggu selama 60 minggu, yakni suatu regimen pengobatan yang 
diketahui dapat mempercepat penurunan produksi progesteron oleh testis dan menyebabkan azoospermia dalam waktu 
12 minggu. Data tentang kadar sperma ditransformasi dalam bentuk log terlebih dahulu sebelum dianalisis. Hasil 
dinyatakan dalam bentuk nilai rerata±SEM. ANOVA yang diikuti oleh uji post hoc digunakan dalam penelitian ini 
untuk menentukan perbedaan lintas waktu dan fase. Uji T dilakukan untuk menentukan perbedaan antar dua kelompok. 
Hasil: ditemukan apoptosis dalam bentuk peningkatan sel-sel germinal (80%) yang mengalami apoptosis secara 
bermakna ketika tikus diberikan TU+DMPA. Sel-sel germinal yang mengalami apoptosis dapat ditemukan pada 
beberapa spermatogonia (20%), spermatosit (30%), dan spermatid (50%). Kesimpulan: pemberian hormon 
TU+DMPA dalam dosis tertentu mungkin merupakan cara yang aman dan efektif dalam mengembangkan 
kontrasepsi pria yang cukup potensial.
Kata kunci: TU, DMPA, kadar sperma, apoptosis.
ABSTRACT
Aim: to investigate the safety and effectiveness of dose TU+DMPA hormones in developing potential male 
contraceptives. Methods: suppression of rat sperm concentration through increased apoptotic germ cells by 
in vivo administration of a long-acting androgen composed of a combination of testosterone undecanoate 
(TU) and depot medroxyprogesterone acetate (DMPA) was performed. Adult Sprague-Dawley rats received 
2.5 mg TU every 6 week and 1.25 mg DMPA every 12 week for 60 week, a regimen known to rapidly reduce 
testosterone production by the testes and produce azoospermia within 12 week. Sperm concentration data were 
log transformed before analysis. Results are expressed as the mean±SEM. ANOVA, followed by post hoc test was 
used to determine differences across time and phase. T test was employed to determine differences between two 
groups. Results: apoptosis revealed significant increase in apoptotic germ cells (80% when rats were administered 
with TU+DMPA. Apoptotic germ cells can be found in several spermatogonia (20%), spermatocytes (30%), 
and spermatids (50%). Conclusion: dose TU+DMPA hormones may be a safe and effective way to develop 
potential male contraceptives.
Key words: TU, DMPA, sperm concentration, apoptosis.
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INTRODUCTION
Since World Health Organization studies 
using a prototype androgen-alone regimen, 
second-generation hormonal regimens featuring 
a combination of an androgen with a second 
gonadotropin-suppressing agent have been 
proven to be more effective than androgen-alone 
regimens.1 Although GnRH antagonists are 
expensive and locally irritating2 and estradiol 
is not sufficiently effective at tolerable doses3, 
numerous synthetic progestins have become 
available, with several progestin/androgen 
combination regimens showing promise for 
suppression of germ cells.4,5 A few studies 
have used a depot hormonal approach6,7 but 
no efficacy studies of a hormonal depot or an 
androgen/progestin combination have yet been 
reported. A desirable feature in a hormonal male 
contraceptive is freedom from high demands on 
medication compliance.
In a more recent dose-finding study in 
Indonesia, spermatogenesis was rapidly and 
completely suppressed after the administration 
of 500 mg TU in tea seed oil every 6 week 
in combination with 250 mg DMPA every 12 
week.8 One explanation for this result is that 
the combination of TU and DMPA induces 
a more profound inhibition of gonadotropin 
and endogenous T levels, as evidenced by 
the suppression of serum LH and FSH, and 
spermatogenesis. One of the most susceptible 
pathways by which to disrupt spermatogenesis is 
interference with the function of the hypothalamic-
pituitary-gonadal axis. This axis regulates 
spermatogenesis by controlling circulating levels 
of luteinizing hormone and follicle-stimulating 
hormone (FSH) through feedback regulation of 
the hormones.9
A number of approaches for male hormonal 
contraception using testosterone (T) esters have 
been widely investigated.10 In several studies, 
an androgen ester has been administered to 
both consistently suppress gonadotropin and 
serve as an androgen replacement. Azoospermia 
could be achieved in 80% of Chinese men11 
and 94.7% of Indonesian fertile men12 by 
administration of the androgen ester at 8 week 
and 6 week intervals, respectively. Intratesticular 
testosterone is decreased by suppression of 
gonadotropin secretion. In fact, caspase-3 
activation has been shown to occur in rat germ 
cells within 1 week during in vivo reduction of 
intratesticular testosterone, and internucleosomal 
DNA cleavage in germ cells continues to increase 
through the subsequent 3 week.13 Kim et al. 
(2001)14 examined the roles of caspase-3 and 
CAD activation in relation to the apoptotic death 
of germ cells. They showed that testosterone 
withdrawal results in spermatocyte apoptosis, 
and that this apoptosis is correlated with 
activation of caspase-3, as well as increased 
CAD protein expression. These results suggest 
that spermatocyte apoptosis, resulting from 
reduced intratesticular testosterone, is mediated 
by caspase-3 activation and CAD.
The present study is designed to estimate 
the contraceptive efficacy of a combination of 




Adult male Sprague-Dawley rats (150 g to 
250 g), purchased from BPOM Depkes RI Jakarta, 
were housed four per cage in a light-controlled 
room (12 h light:12 h darkness; lights on at 0700 
H). The animals were handled daily for at least 1 
week prior to the beginning of experimentation; 
food and water were available ad libitum. Rats 
were injected i.m. with either TU (1.25 mg/
kg body weight at 6 week intervals) or DMPA 
(2.5 mg/kg body weight at 12 week intervals). 
The animals were killed by administration of an 
overdose of anesthetic at specific time points, 
and their testes were removed and weighed. The 
left and right testes were processed for histology 
after fixing in Bouin’s solution.
Androgen/Progestin Preparation
Injectable testosterone undecanoate (Nebido) 
was manufactured by Schering AG, Germany and 
was provided in ampoules containing 1000 mg of 
the ester in 4 mL of castor oil. The same batch of 
TU was used throughout the study. DMPA was 
manufactured and distributed by a pharmacy in 
Jakarta. The registered trade name for this product 
is Depo-Geston. The compound was formulated 
as an aqueous suspension and packaged in 3 mL 
vials containing 150 mg DMPA.
Study Procedure
The study consisted of a pretreatment phase 
lasting at least 4 week, a suppression phase 
lasting 24 week, a maintenance phase lasting 
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36 week, and a recovery phase lasting 12 week.
During pretreatment phase period, three fluid 
samples were taken from the left and right cauda 
epididymis. Upon completion of the pretreatment 
period, 40 rats were randomly assigned to receive 
one of the following regimens: a) TU 2.5 mg 
(every 6 week) plus DMPA 1.25 mg every 12 
week (treatment group) for 24 week. b) Control 
to treatment group (control group) for 24 week.
During the maintenance period, about 36 
week, the rats received injections according 
to the schedule of the group to which they 
were assigned. During the recovery phase, rats 
underwent physical and sperm concentration 
examinations every 6 week for 12 week.
In-situ and Labeling of DNA in Apoptotic Cells
One testis from each rat was fixed in Bouin’s 
fluid and paraffin embedded. Apoptotic cells 
were identified in tissue sections (5 mm) by ISEL 
using an in-situ death detection kit, POD (Cat 
No. 11 684 817 001, Roche). Briefly, sections 
were deparaffinized in xylene and rehydrated in 
a graded ethanol series (100%, 95%, 80%, and 
70%), followed by phosphate-buffered saline 
(PBS; 10 mM sodium phosphate dibasic, 1.8 
mM potassium phosphate monobasic, 137 mM 
NaCl, 2,7 mM KCl, pH 7,4). The sections were 
digested with buffer citrate for 30 min at 95°C, 
washed with PBS, and then treated with PBS 4°C 
for 2 min. Sections were incubated with terminal 
deoxynucleotidyl transferase reaction mixture 
for 1.5 h at 37°C in a humidified atmosphere 
and the reaction stopped by immersion in buffer. 
Sections were then washed in PBS and incubated 
with peroxidase-conjugated anti-digoxygenin 
for 30 min at room temperature in a humid 
atmosphere. Following washing in PBS, sections 
were incubated with diaminobenzidene (DAB) 
substrate for 10 min at room temperature, washed 
in distilled water, dehydrated stepwise in ethanol 
(70%, 80%, 95%, and 100%) and xylene, and 
mounted with entelan. For quantification, slides 
were blinded and all tubules in two different 
sections of testis were counted for the absence or 
presence of 1 to 3 or >3 TUNEL-positive germ 
cells. For every animal, at least 400 tubules were 
scored for TUNEL positivity (modified method 
from Rasoulpour and Boekelheide, 2005).15
Statistical Analysis
Sperm concentration data were log 
transformed before analysis. Results are expressed 
as the mean±SEM. P<0.05 was considered to be 
significant.
ANOVA, followed by post hoc test (software 
package, SPSS 13) was used to determine 
differences across time and phase. T test was 
employed to determine differences between two 
groups.
RESULTS
Germ Cell Apoptosis During in-vivo TU+DMPA 
Injection of Rats 
The timing of germ cell apoptosis in relation 
to TU+DMPA injection in-vivo was studied 
by TUNEL assay to examine the possible 
involvement of germ cell apoptosis in TU+DMPA-
induced azoospermia. Means of germ cell 
apoptosis in treated groups gradually increased 
during injections of the first and end regimens, 
and a significant increase was found at the 6th 
week of the treatment period when compared 
with pretreatment values. Means of germ cell 
apoptosis were maintained at very high levels 
throughout the 60 week of the treatment period 
(Figure 1). A trend towards a more sustained 
increase in germ cell apoptosis was observed 
in TU+DMPA combination groups compared 
with the control group, and their difference was 
significant (P<0.05). Germ cells began to recover 
during the recovery period (after cessation of 
TU+DMPA administration). By the 12th week 
of the recovery period, mean caspase-3 positive 
germ cells in the treated group had returned to the 
normal reference range (39.37±5.32 cells/400 of 
tubules), and no significant (P>0.05) difference in 
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Figure 1. Quantification of the percentage of TUNEL-positive 
seminiferous tubules with 1 to 3 or >3 TUNEL-positive cells 
at 0, 3, 6, 12, 18, 24, 30, 36, 42, 48, 54, 60, 66, and 72 wk 
(n; 5-5) during TU+DMPA or control (n;5-5) treated rat testes. 
Significant differences (P<0.05) are indicated by different 
letters. K0, pretreatment; K1, suppression; K2, maintenance; 
K3, recovery, C = control and T = treatment group
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period were compared with the pretreatment of 
germ cell apoptosis in the untreated and treated 
groups.
All data were divided into four phases: 
pretreatment, suppression, maintenance, and 
recovery; these phases are shown in Figure 2.
Localization of Germ Cell Apoptosis During 
TU+DMPA Injection in Vivo
TUNEL assay was used to further examine the 
possibility of relationship between TU+DMP0A-
induced apoptosis germ cells (Figure 3). Germ 
cells in the testes of rats were germ cell apoptosis 
negative (yellow arrow; Figure 3A), and cells 
showed evidence of germ cell apoptosis in the 
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Figure 2. Percentage of tubules with TUNEL positive Cells 
in each phase during TU combined with DMPA for 72 wk. 
Values are expressed as the mean±SEM. 






Figure 3. Localization apoptosis germ cells in germ cells 
pretreatment (A, control; E, treated) suppression (B, control; 
F, treated), maintenance (C, control; G, treated) and recovery 
(D, control; H, treated) phase post-TU+DMPA injection.
shown in Figure 4. Azoospermia or severe 
oligozoospermia was achieved and maintained in 
all rats during the suppression and maintenance 
phases, but sperm rebound occurred in one rat 
[sperm concentrations were 16.33±1.53 million/
mL] in the TU+DMPA group. A trend towards a 
more sustained suppression of spermatogenesis 
was observed in TU+DMPA combination groups 
than in the control group, and their difference 
was significant (P<0.05). Spermatogenesis 
began to recover during the recovery period. 
However, recovery of spermatogenesis in 
the two combination groups was delayed and 
azoospermia was maintained for an additional 
6 week after cessation of the treatment period. 
By the 12th week of the recovery period (at 
72 week), the mean sperm concentration in 
the treated group had returned to the normal 
reference range [(109.47±27.52) million/mL], 
and no significant difference (P>0.05) in this 
parameter was observed when values at this 
period were compared with sperm concentrations 
in the control group (Figure 5).
Sperm Concentration
Distribution of the rats and times for achieving 
azoospermia or severe oligozoospermia (≤3 










































Figure 4. Percentage of azoospermia among rats receiving 

































Pretreatment Suppression Maintenance Recovery
Figure 5. Mean sperm concentrations in each group during 
TU combined with DMPA at 6 wk injection intervals. Values 
are expressed as mean±SEM. Arrows indicate hormone 
injections. The y-axis is represented as a log scale. ♦, Control 
group; ■, Treatment group.
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Correlation Between Sperm Concentration 
and Germ Cell Apoptosis After Administration 
of TU+DMPA
When data were treated at the cellular level 
using comparisons with the relative controls, 
sperm concentration appeared significantly 
associated (P<0.000) with the presence of germ 
cell apoptosis (Figure 6). 
spontaneous apoptosis occurs at various phases of 
germ cell development and mainly in pre-meiotic 
cells. In addition to spontaneous apoptosis, 
apoptotic cell death of rat germ cells can be 
induced during administration of TU+DMPA 
combination (Figure 1). The influence of 
TU+DMPA injection decreases intratesticular 
testosterone. Adult mammalian spermatogenesis 
is a testosterone-dependent process, and many 
studies have shown that testosterone withdrawal 
from the rat testis results in increased germ 
cell apoptosis. However, the mechanism by 
which testosterone regulates spermatogenesis 
remains uncertain.17,18 In Nandi’s study,19 ethane 
1,2-dimethanesulfonate (EDS), a Leydig cell 
toxicant, was used to kill Leydig cells, thus 
reducing intratesticular testosterone levels in 
Sprague-Dawley rats. After the treatment, germ 
cell apoptosis and testicular fas protein expression 
increased.19 In another similar study conducted 
by Woolveridge’s group, they found that 8 day 
after treatment with EDS, germ cell apoptosis 
index increased 24-fold compared with the 
control group. After withdrawal of androgen, no 
significant changes in Bcl-xl, Bak, and Bad levels 
were observed. However, the expressions of 
Bcl-2 and Bax were upregulated.20 Cell adhesion 
has been shown to play an essential role in the 
regulation of programmed cell death in epithelial 
cells, known as FSH, and testosterone withdrawal 
results in the triggering of apoptosis, as well as 
germ cell detachment from the seminiferous 
epithelium. After hormone suppression by short-
term estradiol benzoate treatment of rats, germ 
cell apoptosis was observed, and the triggering 
of apoptosis preceded germ cell detachment.21 
Addition of TU+DMPA resulted in improved 
suppression of germ cells to azoospermia. A 
long-acting TU+DMPA treatment given twice 
weekly has shown promise in a small number of 
subjects, producing an azoospermia rate of 80% 
at 18 week and, as such, is worthy of further 
consideration. However, problems associated 
with local injection site reactions, including 
erythema and induration, continue to arise. 
Good correlation was observed between the 
number of apoptotic germ cell and the number of 
sperm concentration in all testicular specimens 
(P<0.01, Spearman’s rank = -0.700). Although 
the causes and molecular mechanisms involved 
in germ cell apoptosis are far from defined, 
programmed cell death appears to be important to 
Percentage of Tubules with TUNEL
positive Cells
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Figure 6. Regression diagram of apoptosis germ cells vs. 
mean of sperm concentration
DISCUSSION
The present study demonstrated that TU 
treatment every 6 week and TU+DMPA treatment 
every 12 week at doses of TU 1.25 mg/kg 
and DMPA 2.5 mg/kg, significantly influence 
apoptotic germ cells in rats. TU+DMPA slightly 
suppressed spermatogenesis during the 60 
week treatment, whereas severe suppression 
resulted after continued treatment for 24 week. 
Recovery occurred 72 week after cessation of 
TU+DMPA treatment. However, such a degree 
of suppression may still lead to azoospermia, a 
possible explanation for which is that germ cells 
suppression may be associated with the impaired 
release of late spermatids, as observed in men 
and monkeys.6 After TU+DMPA treatment for 
18 week, 80% of the rats became azoospermic. 
Few studies have investigated whether or not 
spermatogenesis, in terms of germ cell numbers, 
could fully recover after drug treatment that 
induces gonadotropin withdrawal. Hikim and 
Swerdloff (1999)16 reported a complete reversal 
of late spermatid number, testicular weight, 
and tubule diameter 6 week after cessation of 
Nal-Glu-GnRH treatment in rats. The present 
study also showed the complete restoration of 
spermatogenesis after TU+DMPA suppression. 
During normal adult spermatogenesis, 
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adjust germ cell numbers to that of the supporting 
Sertoli cells and ensure quality control of the 
gametes produced.
Apoptotic germ cell return decreased at the 
maintenance phase (P>0.05) versus the control 
or pretreatment phase. Long-acting TU+DMPA 
injection increased the number of apoptotic germ 
cells significantly, which was reversible when 
injection was discontinued. Taken together, the 
data essentially illustrate the important role of 
apoptosis in the proposed combination-drug 
contraception, and the extent of apoptosis was 
TU+DMPA dose-dependent. Both intrinsic and 
extrinsic pathways participate in the process.
CONCLUSION
The use of TU+DMPA hormones may be a 
safe and effective way to develop potential male 
contraceptives, and further studies on this topic 
should be carried out.
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